To obtain the durable bene tsofopioid analgesia, physicians must develop strategies to manage the negative attributes of opioid therap_v. Side 
Introduction he use of opioids for analgesia has a complex history that continues to color opioid use today. Opioid analgesics, at one time, were considered more troublesome than useful. Their side effects and potentials for abuse prompted physicians to underutilize this analgesia tool with the result that much acute pain and pain from terminal diseases went untreated [1, 2] . Today, the medical consensus is that opioid analgesia is a powerful and appropriate treatment for many patients confronting severe pain [3] and that its bene ts reach beyond analgesia to encompass mood, functioning, and quality of life [4] . Although opioids were S40 [12] . Both opioid-induced hyperalgesia and opioid tolerance result in the need for increasing doses of opioids to maintain equivalent analgesia, but it is not clear whether opioid-induced hyperalgesia and opioid tolerance are related, independent, or competing conditions. Opioid tolerance is a better-known pharmacologic phenomenon that develops over time and requires the titration of opioid doses to maintain analgesic effect [13] ; however, dose escalation carries the risks of toxicity and of more or exacerbated side effects. There are two types of tolerance, associative (learned) and nonassociative (adaptive), which appear to involve distinctly different neurotransmitters in the body. Associative (or conditioned) tolerance is situational and contextual, i.e., it depends on the animal forming associations with the environment [14] . For example, animals receiving morphine in a distinctive environment display greater morphine tolerance when tested in that environment than when tested in an unfamiliar environment. In such a situation, animals might display an opposite compensatory response that summates with the druginduced effect, even leading to hyperalgesia if the drug is withheld in the presence of environmental cues [15] . The relative ability and clinical relevance of individual opioids to produce compensatory reactions are not known. By contrast, nonassociative tolerance takes place at the cellular level and involves a reduction in turnover rate or number of opioid receptors, their desensitization, or both [16, 17] . Because tolerance results from a change in the opioid receptor transduction system (receptor-effector coupling) and downstream second-messenger biochemical pathways that are common to all opioids, tolerance to one opioid analgesic is accompanied by tolerance to all others that act at the same receptor (a phenomenon known as cross-tolerance). Functionally, tolerance or cross-tolerance is manifested as a rightward shift in the opioid's dose-response curves (therapeutic and side effect). The [18] .
Opioid rotation is the change from one opioid to another in a patient whose treatment may be limited by toxicity levels produced by a particular opioid [19] . Owing to the vast variation in individual responsiveness to opioids [20] , clinicians have observed that changing opioids can sometimes improve analgesia while simultaneously reducing side effects [21] . One of the main concerns in opioid rotation is transitioning from one drug to the next while maintaining equianalgesia without over-or under-dosing the patient. Many experts recommend establishing an equianalgesic dose and then reducing it, sometimes by as much as 50% at the outset of rotation, to account for incomplete cross-tolerance [22] . Although opioid dosing guidelines exist, a prospective study (N = 132) found that errors in opioid conversion and rotation were not uncommon [23] .
A retrospective analysis of 37 rotations oflongacting opioids and 59 rotations of short-acting opioids to long-acting opioids found that rotations resulted in significantly improved analgesia in both groups (59% of patients rotated between long-acting opioids and in 73% of those rotated from short-acting to long-acting opioids), while rotations of long-acting opioids to other longacting opioids also reduced side effects [24] . A small prospective study (N :42) 
